|
2024
|
Invention
|
P-ethoxy nucleic acids for liposomal formulation.
Provided herein are therapeutic oligonucleotid... |
|
2021
|
Invention
|
P-ethoxy nucleic acids for stat3 inhibition. Provided herein are improved delivery systems for ol... |
|
|
Invention
|
Combination therapy with liposomal antisense oligonucleotides. Provided herein are methods of tre... |
|
2020
|
Invention
|
P-ethoxy nucleic acids for liposomal formulation. Provided herein are therapeutic oligonucleotide... |
|
2018
|
Invention
|
P-ethoxy nucleic acids for bcl2 inhibition. Provided herein are improved delivery systems for oli... |
|
|
Invention
|
P-ethoxy nucleic acids for igf-1r inhibition.
Provided herein are improved delivery systems for ... |
|
|
Invention
|
P-ethoxy nucleic acids for igf-1r inhibition.
Provided herein are methods of treating cancer or ... |
|
|
Invention
|
P-ethoxy nucleic acids for igf-1r inhibition. Provided herein are improved delivery systems for o... |
|
|
Invention
|
P-ethoxy nucleic acids for igf-1r inhibition. Provided herein are methods of treating cancer or a... |
|
2015
|
P/S
|
Pharmaceutical preparations containing liposomes for use as drug delivery agents that facilitate ... |
|
|
P/S
|
Patent licensing; licensing intellectual property |
|
|
P/S
|
Product development for others; platform technology, namely, lipid-based platform for research an... |
